Us-listed Chinese stocks posted their best monthly performance since the beginning of 2019. At a time when US stocks are stumbling over fears of a recession, investors in pursuit of high returns have poured into the US-listed market. The Nasdaq Golden Dragon China index rose 16 per cent in June for the first time since February 2021, following a 2.6 per cent rise in May. New Oriental Education & Technology Group was the top gainer, with a cumulative increase of 56 per cent, while both Li Auto Inc. and XPeng Inc. rose more than 30 per cent. BABA rose 18%.
在美上市中概股扬眉吐气 跑赢美股并创三年来最佳单月表现
Listed in the United States, Chinese stocks proudly outperformed US stocks and achieved their best monthly performance in three years.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.